BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26463684)

  • 1. An internal pilot design for prospective cancer screening trials with unknown disease prevalence.
    Brinton JT; Ringham BM; Glueck DH
    Trials; 2015 Oct; 16():458. PubMed ID: 26463684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A SAS macro for sample size adjustment and randomization test for internal pilot study.
    Wang S; Xia J; Yu L; Li C; Xu L
    Comput Methods Programs Biomed; 2008 Apr; 90(1):66-88. PubMed ID: 18192069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blinded sample size re-estimation in three-arm trials with 'gold standard' design.
    Mütze T; Friede T
    Stat Med; 2017 Oct; 36(23):3636-3653. PubMed ID: 28608469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of internal pilots with the univariate approach to repeated measures.
    Coffey CS; Muller KE
    Stat Med; 2003 Aug; 22(15):2469-85. PubMed ID: 12872303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sample size re-estimation in group-sequential response-adaptive clinical trials.
    Morgan CC
    Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials with nested subgroups: Analysis, sample size determination and internal pilot studies.
    Placzek M; Friede T
    Stat Methods Med Res; 2018 Nov; 27(11):3286-3303. PubMed ID: 29298604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blinded sample size recalculation in multicentre trials with normally distributed outcome.
    Jensen K; Kieser M
    Biom J; 2010 Jun; 52(3):377-99. PubMed ID: 20394080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample-size calculation and reestimation for a semiparametric analysis of recurrent event data taking robust standard errors into account.
    Ingel K; Jahn-Eimermacher A
    Biom J; 2014 Jul; 56(4):631-48. PubMed ID: 24817598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling test size while gaining the benefits of an internal pilot design.
    Coffey CS; Muller KE
    Biometrics; 2001 Jun; 57(2):625-31. PubMed ID: 11414593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On sample size estimation and re-estimation adjusting for variability in confirmatory trials.
    Wu PS; Lin M; Chow SC
    J Biopharm Stat; 2016; 26(1):44-54. PubMed ID: 26378970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exact test size and power of a Gaussian error linear model for an internal pilot study.
    Coffey CS; Muller KE
    Stat Med; 1999 May; 18(10):1199-214. PubMed ID: 10363340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-calculating the sample size in internal pilot study designs with control of the type I error rate.
    Kieser M; Friede T
    Stat Med; 2000 Apr; 19(7):901-11. PubMed ID: 10750058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internal pilots for observational studies.
    Gurka MJ; Coffey CS; Gurka KK
    Biom J; 2010 Oct; 52(5):590-603. PubMed ID: 20857422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blinded sample size recalculation in clinical trials with binary composite endpoints.
    Sander A; Rauch G; Kieser M
    J Biopharm Stat; 2017; 27(4):705-715. PubMed ID: 27295402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size re-estimation incorporating prior information on a nuisance parameter.
    Mütze T; Schmidli H; Friede T
    Pharm Stat; 2018 Mar; 17(2):126-143. PubMed ID: 29181869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blinded sample size re-estimation in crossover bioequivalence trials.
    Golkowski D; Friede T; Kieser M
    Pharm Stat; 2014; 13(3):157-62. PubMed ID: 24715672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size reassessment in non-inferiority trials. Internal pilot study designs with ANCOVA.
    Friede T; Kieser M
    Methods Inf Med; 2011; 50(3):237-43. PubMed ID: 20213039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing decision errors in the paired comparison of the diagnostic accuracy of screening tests with Gaussian outcomes.
    Ringham BM; Alonzo TA; Brinton JT; Kreidler SM; Munjal A; Muller KE; Glueck DH
    BMC Med Res Methodol; 2014 Mar; 14():37. PubMed ID: 24597517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blinded and unblinded internal pilot study designs for clinical trials with count data.
    Schneider S; Schmidli H; Friede T
    Biom J; 2013 Jul; 55(4):617-33. PubMed ID: 23703749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of the two-sample t-test statistic following blinded sample size re-estimation.
    Lu K
    Pharm Stat; 2016 May; 15(3):208-15. PubMed ID: 26865383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.